Barrington raised the firm’s price target on Imax (IMAX) to $32 from $30 and keeps an Outperform rating on the shares following the Q4 report. The firm cites the company’s outlook for profit growth from box office improvement for the target increase. It sees demand in multiple markets supporting Imax’s growth.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMAX:
- Imax price target raised to $32 from $30 at Roth MKM
- Imax price target raised to $32 from $28 at Barrington
- IMAX’s Promising Future: Strong 2025 Performance and Strategic Partnerships Drive Buy Rating
- IMAX Corporation Reports Strong 2024 Financial Results
- IMAX Corporation Reports Strong 2024 Financial Results and Sets Sights on Record 2025